Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
64.13
-2.24 (-3.38%)
At close: Aug 25, 2025, 4:00 PM
64.40
+0.27 (0.42%)
After-hours: Aug 25, 2025, 5:30 PM EDT
Cidara Therapeutics Employees
Cidara Therapeutics had 38 employees as of December 31, 2024. The number of employees decreased by 31 or -44.93% compared to the previous year.
Employees
38
Change (1Y)
-31
Growth (1Y)
-44.93%
Revenue / Employee
n/a
Profits / Employee
-$3,091,842
Market Cap
1.63B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 38 | -31 | -44.93% |
Dec 31, 2023 | 69 | -4 | -5.48% |
Dec 31, 2022 | 73 | -16 | -17.98% |
Dec 31, 2021 | 89 | 9 | 11.25% |
Dec 31, 2020 | 80 | 12 | 17.65% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CDTX News
- 10 days ago - Cidara Therapeutics: Still Big Catalysts Ahead Following Impressive Ph2b Readout - Seeking Alpha
- 17 days ago - Cidara Therapeutics, Inc. (CDTX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025 - GlobeNewsWire
- 7 weeks ago - Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics - Business Wire
- 7 weeks ago - Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 2 months ago - Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 2 months ago - Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire